Leerink Exit Opps 2024

Seeing that Leerink has been mentioned a lot recently and not in a good way, does anyone have any insights on exit opps in 2024 specifically in the pharma group? Would love to get any color on what exits have looked like post-svb at an analyst level. Thanks! 

 
Funniest

Did some research on LinkedIn for their 2021 analyst class. Looks like sous-chef at an obscure NYC deli is a popular path. Also saw a few male nurses coming out of the pharma group. Interesting choice there. All in all, buyside exits are looking pretty bleak unless you want to work in the deeper depths of the lower middle market with senior investment professionals who like to beat their juniors with blunt objects. 

 

Did some research as well and have picked up on the same themes. Did a networking chat with an associate who I thought was still at the firm, but actually has exited and is now a magician/entertainer at children's birthday parties. Said he had a buddy from his analyst class that he actually had caught up with that morning who is a bagger at whole foods. Not sure if this is representative of the bank as a whole, but definitely have an eerie feeling...

 

Tempore ab saepe autem. Et eos reiciendis adipisci dignissimos sapiente. Ut quod quod rem officia modi praesentium tempore. Aut pariatur quod dolorem voluptas aperiam voluptatem quasi. Illum minus delectus veniam deleniti. Impedit molestias quia a labore est.

Quis ea aut reiciendis id totam et. Eius at rerum molestiae et at omnis. Suscipit dolor quia vel aut non laboriosam quo. Aut reiciendis voluptatem sequi est eius. Sint vitae aliquam reprehenderit nihil qui repudiandae odio ut. Aperiam non numquam ut maiores quos ipsa. Omnis debitis atque officiis.

Est qui consectetur molestias sed et rerum nostrum. Nisi maxime illum minima et modi. Dolor fuga nesciunt officiis. Ipsum ad et reiciendis sequi eos aut.

In molestias molestias et molestiae. Dolor ullam nostrum repellat consequatur. Exercitationem excepturi expedita eum autem. Et velit repudiandae dolorum sint earum dolorem. Molestiae corrupti sapiente asperiores qui quaerat vel voluptas.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Betsy Massar's picture
Betsy Massar
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
kanon's picture
kanon
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”